Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder

NCT02191397 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

534

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Bupropion
DRUG: Bupropion Matching Placebo
DRUG: Escitalopram
DRUG: Escitalopram Matching Placebo

Sponsor

GlaxoSmithKline